Literature DB >> 4359746

Plasma testosterone: an accurate monitor of hormone treatment in prostatic cancer.

R J Shearer, W F Hendry, I F Sommerville, J D Fergusson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4359746     DOI: 10.1111/j.1464-410x.1973.tb12238.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


× No keyword cloud information.
  14 in total

Review 1.  [Problems and principles of hormone therapy of advanced prostate cancer].

Authors:  J E Altwein; P Faul
Journal:  Klin Wochenschr       Date:  1990-04-02

Review 2.  Hormonal aspects of prostatic cancer: a review.

Authors:  J Waxman
Journal:  J R Soc Med       Date:  1985-02       Impact factor: 5.344

3.  Editorial: Stilboestrol for prostatic cancer.

Authors: 
Journal:  Br Med J       Date:  1974-06-08

4.  Treatment of advanced prostatic carcinoma.

Authors: 
Journal:  Br Med J       Date:  1979-09-29

5.  The influence of medroxyprogesterone acetate (MPA) on hormone parameters in prostatic carcinoma patients.

Authors:  J Flamm; J Spona
Journal:  Int Urol Nephrol       Date:  1988       Impact factor: 2.370

6.  Advanced carcinoma of the prostate- does the pre-treatment Leydig cell function determine the response to orchidectomy?

Authors:  A L Houghton; H S Jacobs
Journal:  Postgrad Med J       Date:  1978-04       Impact factor: 2.401

7.  Adenocarcinoma of the prostate in perspective.

Authors:  A W Bruce; D E Mahan
Journal:  Can Med Assoc J       Date:  1978-11-04       Impact factor: 8.262

8.  Testosterone metabolism in patients with advanced carcinoma of the prostate: a comparative in vivo study of the effects of oestrogen and antiprolactin.

Authors:  G H Jacobi; K Sinterhauf; K H Kurth; J E Altwein
Journal:  Urol Res       Date:  1978

Review 9.  Estramustine phosphate sodium. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in prostate cancer.

Authors:  C M Perry; D McTavish
Journal:  Drugs Aging       Date:  1995-07       Impact factor: 3.923

Review 10.  Hormonal therapy for stage D cancer of the prostate.

Authors:  M R Gudziak; A Y Smith
Journal:  West J Med       Date:  1994-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.